INJECTION TECHNIQUE IS IT IMPORTANT? Anders Frid, MD, PhD, T.I.T.AN Athens

Similar documents
Lessons learned from working with international injection technique guidelines

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.

ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:

Insulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin

Gentle and safe injections. Tips and tricks for injecting insulin.

Currently available intermediate- and

A Fact Sheet for Parents and Carers Insulin and Diabetes

Sponsor / Company: Sanofi Drug substance(s): insulin glargine (HOE901) According to template: QSD VERSION N 4.0 (07-JUN-2012) Page 1

Gentle and safe injections. Tips and tricks for injecting insulin.

Nph insulin conversion to lantus

Information for all patients taking insulin who are admitted to hospital on day of surgery

Iso-Insulin ELISA ( ), Brochure

Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University

Providing Stability to an Unstable Disease

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

Exogenous Insulin in type 2 DM

New basal insulins Are they any better? Matthew C. Riddle, MD Professor of Medicine Oregon Health & Science University Keystone Colorado 15 July 2011

Insulin analogues Das PP, Datta PG

Safe and Gentle Injection of Insulin. Guide for correct injection technique. Englische Ausgabe

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

Insulin Prior Authorization with optional Quantity Limit Program Summary

Type I Type II Insulin Resistance

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??

DAFNE Audit Auditor Questionnaire

Position Statement of ADA / EASD 2012

Injection technique for different needle lengths

BEST 4 Diabetes. Optimisation of insulin module

What do you need to know before you go home?

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

Fat Mass. Baseline. (lbs) (lbs) Composition Trend: Total. Aug 17. Apr 17. May 17. Jun 17. Jul 17. Measured Date

Basics&of&Diabetes&and&Medications& Educational&Handouts&

Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis

Patient Education Pharmacy Services

BEST 4 Diabetes. Optimisation of insulin module

INSULIN 101: When, How and What

If you inject diabetes medication, you should know how important correct injection technique is for effectively managing your diabetes.

LEVEMIR (insulin detemir) subcutaneous solution LEVEMIR FLEXTOUCH (insulin detemir) subcutaneous solution pen-injector

Correct Site Rotation

Clinical Guiding Principles for Subcutaneous Injection Technique. Technical Guidelines

Pathogenesis of Type 1 Diabetes. Diabetes Mellitus Type 1. Pathogenesis. Pathogenesis of DM1. Type 2. Type 1. Genetics of Type 1 Diabetes

WooSuk University. Hwang, Moon Sook

Living Well Successfully managing diabetes

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

Scottish Medicines Consortium

Insulin Regimens: Hitting Glycemia Targets

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

PRINCIPLES OF INSULIN THERAPY

Drugs used in Diabetes. Dr Andrew Smith

Levemir vs lantus dose conversion

Defining the ideal injection techniques when using 5-mm needles in children and adults

H1N1 Vaccine Administration Manual for Paramedics

Basal Insulin Drug Class Prior Authorization Protocol

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

The Advantages of Short Pen Needles. Insulin injection with pen needles

Parenteral Products. By: Howida Kamal, Ph.D

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Conversion from lantus to tresiba

Agenda. Indications Different insulin preparations Insulin initiation Insulin intensification

insulin and injections

Module 5. Understanding Insulin Therapy

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy

Degludec lantus conversion

Medications for Diabetes

BD Nano 4mm Pen Needles

Basal Bolus Insulin Therapy Frequently Asked Questions

Patient information. Subcutaneous Immunoglobulin Therapy and Home Treatment ( SCIG) Infection and Immunity Directorate PIF 1443 V2

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

LET S TALK INSULIN THE BASICS

MANAGEMENT OF TYPE 1 DIABETES MELLITUS

This program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Sponsor / Company: Sanofi Drug substance(s): HOE901-U300 (insulin glargine)

Mixed Insulins Pick Me

Injecting Insulin into Out Patient Practice

Update on Insulin-based Agents for T2D

Efficacy/pharmacodynamics: 85 Safety: 89

INSULIN INJECTION KNOW-HOW

Injection Technique (I.T.), Glycemic Variability, and Lipohypertrophy. Why I.T. All Matters

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS

RN Diabetes Medication Titration Protocol

Converting lantus to humalog 75 25

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth

08-15 NOVO NORDISK A/S

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

Novel Formulations to Modify Mealtime Insulin Kinetics

Lantus levemir conversion

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT

Sponsor / Company: Sanofi Drug substance(s): HOE901-U300 (insulin glargine) According to template: QSD VERSION N 4.0 (07-JUN-2012) Page 1

Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction

Levemir FlexPen. > 10.0 mmol/l (180 mg/dl) + 8 U mmol/l ( mg/dl) + 6 U mmol/l ( mg/dl) + 4 U

When and how to start insulin therapy in type 2 diabetes

Procedures for taking physical measurements

Guide To Microcannular Liposuction. Guide To Microcannular Liposuction. drpuneetgupta.co.uk

Copyright 2010 Informa UK Limited Not for Sale or Commercial Distribution

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

EASD European Association for the Study of Diabetes

Transcription:

INJECTION TECHNIQUE IS IT IMPORTANT? Anders Frid, MD, PhD, T.I.T.AN Athens

Injection Technique: What Do We Know and What Do We Want to Know? What about insulin absorption? Are modern insulin analogues different from human insulins regarding absorption? In what tissue do we want to deposit insulin? What technique do we use to achieve that? Are different needle lengths suitable for different patient groups?

Injection Technique: What Do We Know and What Do We Want to Know? What about insulin absorption? Are modern insulin analogues different from human insulins regarding absorption? In what tissue do we want to deposit insulin? What technique do we use to achieve that? Are different needle lengths suitable for different patient groups?

Christian Binder 1969: Soluble 131 I-insulin (pig, U40) is absorbed faster from the abdomen compared to thigh with buttock in between. C. Binder: Absorption of injected insulin. Thesis, Copenhagen 1969

Hildebrandt P et al:the absorption of subcutaneously injected short-acting soluble insulin: Influence of injection technique and concentration. Diabetes Care 1983;6,459-62

NPH insulin Henriksen et al: Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site. Diabet Med. 1991 Jun;8(5):453-7.

Effect of intramuscular injection, regular human insulin Diabetes Care. 1990 May;13(5): 473-7

CT of thigh, normal-weight adult male

CT, abdominal area, female with DM2, BMI 28.0

Some Observations of Human Fat Tissue Distribution Adult females Many have less than 8 mm of fat tissue laterally in the thigh All have more than 12 mm of fat tissue in the gluteal area Some may have less than 5 mm of fat tissue laterally in the abdominal area Adult males A majority have less than 5 mm of fat tissue laterally in the thigh All have more than 12 mm of fat tissue in the gluteal area Many have less than 5 mm of fat tissue laterally in the abdominal area

Absorption of Rapid-Acting Insulin Analogs No statistically significant difference between abdomen and thigh in time-to-peak Peak is somewhat lower and effect more protracted in thigh No statistically significant difference in insulin absorption between fat and muscle tissue; however, only studied in resting muscle There is a 100-fold increase in blood flow in the working muscle! International consensus is still to recommend subcutaneous (sc), ie, intralipomatous injection

Absorption of insulin 125 I-Lantus after injection in arm, thigh and abdominal area Disappearance of radioactivity = arm = thigh --------- = abdomen Owens et al, Diabetes Care 23;6,June 2000

Levemir thigh abdomen - arm pmol/l 11000 10500 10000 9500 9000 8500 8000 7500 7000 6500 6000 5500 5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 S.C. - Subcutaneous Mean Profiles of Insulin Detemir by S.C. Injection Site Mean -2 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 Time (hours) Treatment S.C. Deltoid S.C. Abdomen S.C. Thigh Spadille Sweden (fig01_2_1.sas/fig01_2_1.cgm)23apr02

Insulin Levemir, sc and im injection Insulin Detem ir Mean Profiles per Adm. Rou te Insulin Detemir (pmol/l) 40 00 35 00 30 00 25 00 20 00 15 00 10 00 50 0 0 0 3 6 9 12 15 18 21 24 Elapsed Time (hours) i.m. i.v. s. c. Trial ID.: NN304-1320 Each mean profile based on dat a from 16 subject s Note that at least two measurements must be available to calculate a mean concentration of I nsulin Det emi r. Thus at time points where there is one or no valid measurem ents no markings oc cur on the figure e.g. at time points later than 240 minutes for the i.v. adm. route Spadille ApS (08FEB02)

Diabetic Medicine 2005;22:1444-45

What Insulins at What Injection Site? All insulins should normally be given sc Soluble human insulins in the abdominal area NPH-insulins in the thigh or gluteal area Rapid-acting insulin analogs in the abdomen, may be given elsewere Insulin glargine in abdomen, thigh, or gluteal area (no studies), strictly sc Insulin Detemir in the thigh (or gluteal area, no studies), strictly sc Premix insulins abdominal area in the morning; thigh or gluteal area in the afternoon/evening

INJECTION TECHNIQUE IS IT IMPORTANT? Anders Frid, MD, PhD, T.I.T.A.N. Athens 11-12 sep 2009

INJECTION TECHNIQUE OF COURSE IT IS! IS IT IMPORTANT? Anders Frid, MD, PhD, T.I.T.A.N. Athens 11-12 sep 2009